JNJ-38518168
Sponsors
Janssen Research & Development, LLC
Conditions
AsthmaHealthyHepatic ImpairmentRheumatoid Arthritis
Phase 1
A Study to Evaluate the Pharmacokinetics of JNJ-38518168 in Patients With Mild and Moderate Hepatic Impairment Compared With Patients With Normal Hepatic Function
CompletedNCT01863784
Start: 2013-04-30End: 2013-11-30Updated: 2016-05-12
A Study to Investigate the Absorption, Metabolism, and Excretion of JNJ-38518168 After a Single Oral Dose in Healthy Male Participants.
CompletedNCT01970020
Start: 2012-10-31End: 2012-12-31Updated: 2013-10-25
Phase 2
A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma
CompletedNCT01823016
Start: 2013-09-30End: 2015-07-31Updated: 2025-04-29
A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy
TerminatedNCT01862224
Start: 2013-07-31End: 2014-07-31Updated: 2015-07-09